These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8742514

  • 1. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats.
    Wiśniewska RJ, Wiśniewski K.
    Gen Pharmacol; 1996 Jan; 27(1):159-63. PubMed ID: 8742514
    [Abstract] [Full Text] [Related]

  • 2. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989 Jan; 41(6):561-72. PubMed ID: 2485904
    [Abstract] [Full Text] [Related]

  • 3. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Jan; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 4. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Jan; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

  • 5. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
    Wiśniewska RJ, Kupryszewski G.
    Pol J Pharmacol Pharm; 1992 Jan; 44(3):281-7. PubMed ID: 1470565
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin (CCK) and C-terminal fragments of CCK: effects of CCK-33, CCK-8 and CCK-4 in the cardiovascular system of diabetic rats.
    Wiśniewska RJ, Wiśniewski K.
    Gen Pharmacol; 1996 Mar; 27(2):399-405. PubMed ID: 8919664
    [Abstract] [Full Text] [Related]

  • 7. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989 Mar; 41(6):573-83. PubMed ID: 2577226
    [Abstract] [Full Text] [Related]

  • 8. Chronotropic actions of cholecystokinin octapeptide on the rat heart.
    Marker JD, Roberts ML.
    Regul Pept; 1988 Mar; 20(3):251-9. PubMed ID: 3363182
    [Abstract] [Full Text] [Related]

  • 9. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M, Penke B, Telegdy G.
    Acta Physiol Acad Sci Hung; 1982 Mar; 60(4):237-42. PubMed ID: 6314742
    [Abstract] [Full Text] [Related]

  • 10. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
    Sandberg E, Ahrén B, Tendler D, Efendic S.
    Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA, DePasquale MJ, Morrone J, Zorn SH, Bryce D, Lowe JA, McLean S.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [Abstract] [Full Text] [Related]

  • 12. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
    Mineo H, Kamita H, Muto H, Ito M, Hyun HS, Onaga T, Yanaihara N.
    Res Vet Sci; 1997 Apr; 62(2):171-4. PubMed ID: 9243718
    [Abstract] [Full Text] [Related]

  • 13. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ, Wiśniewski K.
    Pol J Pharmacol; 1996 Apr; 48(3):293-7. PubMed ID: 9112665
    [Abstract] [Full Text] [Related]

  • 14. Endogenous CCK depresses contractile activity within the ascending myenteric reflex pathway of rat ileum.
    Storr M, Sattler D, Hahn A, Schusdziarra V, Allescher HD.
    Neuropharmacology; 2003 Mar; 44(4):524-32. PubMed ID: 12646289
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH.
    Cancer Res; 1993 Sep 01; 53(17):3925-9. PubMed ID: 8358719
    [Abstract] [Full Text] [Related]

  • 16. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B, Hedner P, Lundquist I.
    Acta Pharmacol Toxicol (Copenh); 1986 Feb 01; 58(2):115-20. PubMed ID: 3518338
    [Abstract] [Full Text] [Related]

  • 17. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
    Itoh S, Katsuura G, Itoh T, Morimoto T.
    Life Sci; 1994 Feb 01; 55(11):PL213-6. PubMed ID: 8072383
    [Abstract] [Full Text] [Related]

  • 18. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart.
    Wiśniewska R, Wiśniewski K.
    Rocz Akad Med Bialymst; 1996 Feb 01; 41(2):183-90. PubMed ID: 9020529
    [Abstract] [Full Text] [Related]

  • 19. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
    Wu T, Wang HL.
    Eur J Pharmacol; 1996 Jun 27; 307(2):125-32. PubMed ID: 8832213
    [Abstract] [Full Text] [Related]

  • 20. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M, Okabayashi Y, Ohki A, Oka T, Fujii M, Nakamura T, Sugiura N, Yanaihara N, Baba S.
    Am J Physiol; 1986 Apr 27; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.